Abstract:J A Mansurova, Andrey Orekhov, A S Zhunuspekova, A A Kassymova, L K Karazhanova Department of Therapy, Non-Commercial Joint-Stock Company "Semey Medical University", Semey, The Republic of Kazakhstan Correspondence: Andrey Orekhov, Department of Therapy, Non-Commercial Joint-Stock Company "Semey Medical University", Molodogvardeyskaya 34-1 Street, Semey, F18E9T9, The Republic of Kazakhstan, Tel +87774141476, Email Background: The objective of this study is to examine the impact of medication adherence on the timing of non-cardiovascular serious events (NCDS) onset in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods: This prospective study was conducted at a single center and involved 220 ACS patients who underwent sequential PCI with stenting. The Morisky Green Levine Medication Adherence Scale was employed to assess adherence to dual antiplatelet therapy (DAPT) and its impact on NCDS occurrence. Early in their hospitalization, all patients received education at the Coronary Heart Disease School. The survival rates of patients in both the main group and a control group (n=355) were subsequently evaluated. Results: The study findings indicated an inverse relationship between stent thrombosis development (Rho=− 0.334; p=0.001) and the timing of recurrent myocardial ischemia. There was also an inverse correlation between patient adherence and stent thrombosis development (Rho=− 0.275; p=0.009). Non-adherent individuals had a 16.8 times higher likelihood of experiencing stent thrombosis compared to compliant patients (p< 0.001). Following participation in the CHD School program, treatment adherence increased from 56.5% to 88.2%. Education for ACS patients post-stenting was significantly associated with all-cause mortality within the first 6 months (p=0.040). Conclusion: Secondary preventive measures, including education, impact the success of endovascular interventions in both the early hospital phase and the long term. Patient education can serve as a supplementary intervention to enhance DAPT adherence, thus diminishing the risk of recurrent cardiovascular events and mortality post endovascular intervention. Keywords: acute coronary syndrome, percutaneous coronary intervention, adherence, education, dual antiplatelet therapy Coronary heart disease (CHD) remains the leading cause of premature mortality among individuals in good physical condition, resulting in over 7 million fatal cases annually. 1 Among the various manifestations of CHD, acute coronary syndrome (ACS) stands out as particularly severe, carrying a significant risk of adverse cardiovascular outcomes. The widespread adoption of early invasive treatment strategies for ACS has notably enhanced patient outcomes, 2 but ongoing monitoring of such patients has unveiled novel challenges, including recurrent episodes of ischemia, thrombosis, and stent restenosis. Inadequate adherence to long-term treatment regimens following coronary interventions stands as a primary factor contributing to the suboptimal efficacy of therapies. 3 This deficiency leads to heightened occurrences of recurrent cardiovascular complications and elevated mortality rates, consequently escalating healthcare expenditures. Statistical data indicate that merely 40–75% of patients sustain secondary prevention practices post-intervention. 4 Enhancing patient compliance can be achieved through approaches such as training initiatives 5 and the emergence of remote monitoring systems for patients. 6 However, the comprehensive benefits of educating ACS patients have not undergone exhaustive exploration. Nonetheless, current guidelines underscore the importance of comprehensive rehabilitation, 7 including educational components, 8 for individuals with cardiovascular disorders. Thus, the objective of this study was to analyze the influence of treatment adherence on the temporal emergence of adverse cardiovascular complications in ACS patients who have undergone percutaneous coronary interventions (PCI). Additionally, the study aimed to assess the contribution of patient education to secondary prevention efforts targeting ischemic events. This prospective investigation encompassed a cohort of 220 patients diagnosed with acute coronary syndrome (ACS) who were admitted to the cardiology department of the University Hospital "SMU" in the Republic of Kazakhstan. The study spanned from January 2018 to September 2019 and focused on patients who had undergone coronary artery angiography (CAG) followed by stenting of the infarct-related artery. Within this patient group, a subset of 89 individuals (40.5%) experienced recurrent myocardial ischemia after previous percutaneous coronary -Abstract Truncated-

The Impact of Patient Adherence to Dual Antiplatelet Medication Following Percutaneous Coronary Intervention on the Occurrence of Adverse Cardiovascular Events

Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study.

Adherence to dual anti-platelet therapy after acute coronary syndrome and its impact on patient outcome

Adherence to Secondary Prevention Measures after Acute Myocardial Infarction and Its Impact on Patient Outcome—A Nationwide Perspective

Long-term Outcome Analysis of Patients Underwent Percutaneous Coronary Intervention with Prior Ischemic Stroke

Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study

Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification

Prolonged Dual Antiplatelet Therapy in Patients with Non-St-segment Elevation Myocardial Infarction: 2-Year Findings from EPICOR Asia.

Long-term follow-up of antithrombotic management patterns in acute coronary syndrome patients

The Increased Ischemic Risk During the Early Period After Clopidogrel Noncompliance in Patients with Acute Coronary Syndrome: A Meta-Analysis

Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study

[Anticoagulation Status and Adherence in Patients with Atrial Fibrillation Hospitalized for ACS and the Impact on 1-Year Prognosis: a Multicenter Cohort Study].

Compliance of Secondary Prevention in Patients with Coronary Artery Disease Post Coronary Revascularization

Adherence to Cardiac Rehabilitation in Patients with Acute Myocardial Infarction After PCI: A Scoping Review

Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

The impact of primary percutaneous coronary intervention strategies during st-elevation myocardial infarction on the prevalence of coronary microvascular dysfunction

New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational Study

Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial)

Impact of extended dual antiplatelet therapy on clinical prognosis in acute coronary syndrome patients with intermediate or high ischemic risk defined by the GRACE score

Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study